Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis

PaperCitations, authors & open-access status

CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 121 citations, 2020 year and bronze oa status.

121
Citations
2020
Year
bronze
OA Status

Related on ScholarIQ

Diego Delgado
Author
Canadian Journal of Cardiology
Journal
Amyloidosis: Diagnosis, Treatment, Outcomes
Topic
Amyloidosis: Diagnosis, Treatment, Outcomes
Topic
Diabetes Treatment and Management
Topic
Peptidase Inhibition and Analysis
Topic
470M+ articles · free account